NOVOPYXIS INC.
Cambridge, MA · Founded 2013 · CIK 0001613912 · Medtech · Private
Droplette, a piezoelectric transducer-based pulmonary delivery device that administers aerosolized therapeutics to the lower airways via ultra-fine droplets (<3 µm)
novopyxis.com →- Grants
- $994K
- 3 awards
- Sector median: 1
- Raised
- $856K
- 2 Form D · Jul 2017
- 111 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 8
- 4 granted · 4 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2014201520162017201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $343,000 | |
| Private capital raised | Form D · SEC | $512,932 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Droplette: A Platform Technology to Deliver Nucleic Acid Therapeutics Deep into Tissue for the Treatment of Epidermolysis Bullosa and Other Genetic Diseases | $248,585 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Droplette: A Platform Technology for At-Home, Effective, and Rapid Pulmonary Delivery to Reduce Ventilator Use and Hospitalization | $496,791 | |
| Federal grant | Department of Health and Human Services · Phase I · Droplette: A Platform Technology for At-Home, Effective, and Rapid Pulmonary Delivery to Reduce Ventilator Use & Hospitalization | $248,206 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1343 | LYNX DX, INC. | — | $925K |
| 1344 | Aethon Medical | — | — |
| 1345 | Simulated Inanimate Models LLC | — | $900K |
| 1346 | NOVOPYXIS INC. | — | $856K |
| 1347 | Eliaz Therapeutics, Inc. | — | $850K |
| 1348 | WNT SCIENTIFIC LLC | — | — |
| 1349 | Echopoint Medical Ltd | — | $250K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Madhavi GaviniDirector · Executive Officer
- Raja SrinivasDirector
- Daniel VannoniDirector · Executive Officer
Patents
- Fluid Delivery Devices And Methodsgranted
- Compositions And Methods For Modulating AT2R Activitygranted
- Compositions And Methods For Modulating AT2R Activitygranted
- Fluid Delivery Devices And Methodsgranted
- Fluid Delivery Devices And Methodsapplication
- Compositions And Methods For Modulating AT2R Activityapplication
- Fluid Delivery Devices and Methodsapplication
- Compositions and Methods for Modulating AT2R Activityapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.